2seventy bio Inc. When-Issued (TSVTV)
$25.23
$2.34
(10.22%)
As on 06-Jan-2022EDT
Market cap
$621 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
19.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-- Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
--
-
Book Value
$3.2
-
EPS
$-5.2
-
Face value
--
-
Shares outstanding
23,287,500
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
| -1.6 | -7.0 | -- | -- | -- | -- | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
2seventy bio Inc. When-Issued (TSVTV)
|
25.2 | 620.6 | 248.1 | -120.1 | -- | -203 | -- | 19.3 |
| 17.4 | 6,074.3 | 3,117.6 | 157.4 | 14.7 | -- | 36.3 | 188.5 | |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 16.2 | 32.7 | 38.3 | 12.7 | |
| 206.7 | 10,826.1 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 131.0 | |
| 74.8 | 14,630.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 111.6 | 12,065.9 | 830.8 | 54.9 | 3.2 | 8.1 | 248 | 17.3 | |
| 24.5 | 12,236.5 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.9 | |
| 285.6 | 5,693.6 | 290.5 | 197.2 | 82.5 | 19.9 | 29.8 | 5.9 | |
| 68.7 | 6,145.7 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 30.7 | |
| 124.7 | 8,210.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 19.0 |
Shareholding Pattern
View DetailsAbout 2seventy bio Inc. When-Issued (TSVTV)
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and... CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc.(NasdaqGS:TSVT.V) operates independently of bluebird bio, Inc. as of November 4, 2021. Read more
-
Headquarters
--
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for 2seventy bio Inc. When-Issued (TSVTV)
What is the current share price of 2seventy bio Inc When-Issued (TSVTV) Today?
The share price of 2seventy bio Inc When-Issued (TSVTV) is $25.23 (NASDAQ) as of 06-Jan-2022 EDT. 2seventy bio Inc When-Issued (TSVTV) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of 2seventy bio Inc When-Issued (TSVTV)?
Since, TTM earnings of 2seventy bio Inc When-Issued (TSVTV) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
-- |
-- |
2019 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of 2seventy bio Inc When-Issued (TSVTV)?
The 52-week high and low of 2seventy bio Inc When-Issued (TSVTV) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of 2seventy bio Inc When-Issued (TSVTV)?
2seventy bio Inc When-Issued (TSVTV) has a market capitalisation of $ 621 Mln as on 06-Jan-2022. As per SEBI classification, it is a company.
Should I invest in 2seventy bio Inc When-Issued (TSVTV)?
Before investing in 2seventy bio Inc When-Issued (TSVTV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.